MedTrace Logo

Comparison of Three Methods of Hemoglobin Monitoring

NCT01284296 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2012-05-28

Study results available
· View outcomes & findings →

Summary

This study will further investigate the Masimo SpHb \[FDA Approved\] continuous non-invasive hemoglobin monitor in spine surgery patients. (See NCT00792597) We will investigate the effect of enhanced circulation to the finger (which will be attached to the sensor) following a local injection (digital block) of lidocaine (an FDA approved local anesthetic), and assess the accuracy of the SpHb reading as it relates to a standard laboratory hemoglobin value (tHb).

Conditions

  • Digital Block

Interventions

DRUG

Lidocaine digital block

One dose of lidocaine 2% injected locally into one finger (2 mls total)

DEVICE

Masimo SpHb continuous hemoglobin monitor

Masimo SpHb continuous hemoglobin monitor

Sponsors & Collaborators

Principal Investigators

  • Ronald D Miller, MD · University of California, San Francisco

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2011-10-31
Completion
2011-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01284296 on ClinicalTrials.gov